Employment Verification
for Relay Therapeutics.

Fast, secure, and automated employment verification for Relay Therapeutics employees.

Start Relay Therapeutics Verification

$39.99 per verification

Pay only when it works
Median turnaround time
< 50 minutes
Total orders
754,000
Success rate
65%

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company founded in 2015 and headquartered in Cambridge, Massachusetts. The company specializes in developing novel therapeutic approaches using its proprietary Dynamo™ platform, which combines computational and experimental methods to understand protein motion in drug discovery. The company’s technology platform integrates multiple computational and experimental approaches to study protein movement and behavior, enabling the development of potentially more effective therapeutic compounds. Their focus is primarily on precision medicine programs in oncology and genetic diseases. Relay Therapeutics went public in July 2020 through an initial public offering (IPO) on the NASDAQ under the ticker symbol “RLAY.” The company has developed a pipeline of targeted therapies, including RLY-4008 (now known as RLY-2608) for FGFR2-altered cancers and RLY-1971 for RAS-MAP kinase pathway mutations. The company has established collaborations with major pharmaceutical companies, including a partnership with Genentech, a member of the Roche Group, to develop and commercialize RLY-1971. Relay Therapeutics continues to expand its drug discovery efforts through both internal research and strategic partnerships, leveraging its computational platform to identify new therapeutic targets and develop potential treatments for various diseases.

The information on this page is not an endorsement of Truv’s services by Relay Therapeutics and is meant to be purely informational.

Verify Relay Therapeutics Employees

  • Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
  • Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
  • Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.

Category

Biotechnology

Number of employees

200.0500.0

Information sourced from public company data.

Relay Therapeutics Employment Verification FAQs.

You can verify employment for Relay Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Relay Therapeutics and many other employers.

Yes, Truv offers both employment and income verification services for Relay Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.

Most verifications through Truv are completed in under 24 hours.

Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.

Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.

Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Cytovance Biologics, ProteinSimple and Cognate BioServices.

No, the information provided about Truv’s verification services is not an endorsement by the Relay Therapeutics.

Not the employer you were looking for?

Also verified with Truv

Employment Verification for Relay Therapeutics.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company founded in 2015 and headquartered in Cambridge, Massachusetts. The company specializes in developing novel therapeutic approaches using its proprietary Dynamo™ platform, which combines computational and experimental methods to understand protein motion in drug discovery. The company’s technology platform integrates multiple computational and experimental approaches to study protein movement and behavior, enabling the development of potentially more effective therapeutic compounds. Their focus is primarily on precision medicine programs in oncology and genetic diseases. Relay Therapeutics went public in July 2020 through an initial public offering (IPO) on the NASDAQ under the ticker symbol “RLAY.” The company has developed a pipeline of targeted therapies, including RLY-4008 (now known as RLY-2608) for FGFR2-altered cancers and RLY-1971 for RAS-MAP kinase pathway mutations. The company has established collaborations with major pharmaceutical companies, including a partnership with Genentech, a member of the Roche Group, to develop and commercialize RLY-1971. Relay Therapeutics continues to expand its drug discovery efforts through both internal research and strategic partnerships, leveraging its computational platform to identify new therapeutic targets and develop potential treatments for various diseases.

The information on this page is not an endorsement of Truv’s services by Relay Therapeutics and is meant to be purely informational.

Verify Relay Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more

Category

Biotechnology

Number of employees

200.0500.0

Relay Therapeutics Employment Verification FAQ.

You can verify employment for Relay Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Relay Therapeutics and many other employers.

Yes, Truv offers both employment and income verification services for Relay Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.

Most verifications through Truv are completed in under 24 hours.

Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.

Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.

Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Cytovance Biologics, ProteinSimple and Cognate BioServices.

No, the information provided about Truv’s verification services is not an endorsement by the Relay Therapeutics.

Yes, Truv provides an option to « Start a verification » directly from this website for Relay Therapeutics employees and employees of many other organizations.

Not the employer you were looking for?